Adenylosuccinic Acid: An Orphan Drug with Untapped Potential

被引:3
作者
Rybalka, Emma [1 ,2 ,3 ,4 ]
Kourakis, Stephanie [1 ,2 ]
Bonsett, Charles A. [5 ,6 ]
Moghadaszadeh, Behzad [7 ]
Beggs, Alan H. [7 ]
Timpani, Cara A. [1 ,2 ,3 ]
机构
[1] Victoria Univ, Inst Hlth & Sport IHeS, Melbourne, Vic 8001, Australia
[2] Australian Inst Musculoskeletal Sci AIMSS, Inherited & Acquired Myopathy Program, St Albans, Vic 3021, Australia
[3] Univ Melbourne, Melbourne Med Sch, Dept Med Western Hlth, St Albans, Vic 3021, Australia
[4] Univ Childrens Hosp Basel UKBB, Div Neuropaediat & Dev Med, CH-4056 Basel, Switzerland
[5] Dystrophy Concepts Inc, Indianapolis, IN 46226 USA
[6] Indiana Univ, Sch Med, Indianapolis, IN 46202 USA
[7] Harvard Med Sch, Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Div Genet & Genom, Boston, MA 02115 USA
关键词
adenylosuccinic acid; adenylosuccinate; succinyl-AMP; Duchenne muscular dystrophy; ADSSL1; myopathy; metabolic disease; skeletal muscle; purine metabolism; immunometabolism; Nrf2; activation; PURINE NUCLEOTIDE CYCLE; XANTHINE-OXIDASE; URIC-ACID; OXIDATIVE STRESS; METABOLISM; DYSTROPHIN; FUMARATE; GENE; NRF2; HYPERTROPHY;
D O I
10.3390/ph16060822
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Adenylosuccinic acid (ASA) is an orphan drug that was once investigated for clinical application in Duchenne muscular dystrophy (DMD). Endogenous ASA participates in purine recycling and energy homeostasis but might also be crucial for averting inflammation and other forms of cellular stress during intense energy demand and maintaining tissue biomass and glucose disposal. This article documents the known biological functions of ASA and explores its potential application for the treatment of neuromuscular and other chronic diseases.
引用
收藏
页数:20
相关论文
共 91 条
[1]   Iron overload and impaired iron handling contribute to the dystrophic pathology in models of Duchenne muscular dystrophy [J].
Alves, Francesca M. ;
Kysenius, Kai ;
Caldow, Marissa K. ;
Hardee, Justin P. ;
Chung, Jin D. ;
Trieu, Jennifer ;
Hare, Dominic J. ;
Crouch, Peter J. ;
Ayton, Scott ;
Bush, Ashley, I ;
Lynch, Gordon S. ;
Koopman, Rene .
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2022, 13 (03) :1541-1553
[2]   Breakdown of an Ironclad Defense System: The Critical Role of NRF2 in Mediating Ferroptosis [J].
Anandhan, Annadurai ;
Dodson, Matthew ;
Schmidlin, Cody J. ;
Liu, Pengfei ;
Zhang, Donna D. .
CELL CHEMICAL BIOLOGY, 2020, 27 (04) :436-447
[3]   Facilitating understanding of the purine nucleotide cycle and the one-carbon pool - Part I: The purine nucleotide cycle [J].
Arinze, IJ .
BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION, 2005, 33 (03) :165-168
[4]   A Walk in the Memory, from the First Functional Approach up to Its Regulatory Role of Mitochondrial Bioenergetic Flow in Health and Disease: Focus on the Adenine Nucleotide Translocator [J].
Atlante, Anna ;
Valenti, Daniela .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
[5]   Increased Xanthine Oxidase in the Skin of Preeclamptic Women [J].
Bainbridge, Shannon A. ;
Deng, Jau-Shyong ;
Poberts, James M. .
REPRODUCTIVE SCIENCES, 2009, 16 (05) :468-478
[6]   A web-accessible complete transcriptome of normal human and DMD muscle [J].
Bakay, M ;
Zhao, P ;
Chen, J ;
Hoffman, EP .
NEUROMUSCULAR DISORDERS, 2002, 12 :S125-S141
[7]   Metabolites as signalling molecules [J].
Baker, Steven Andrew ;
Rutter, Jared .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2023, 24 (05) :355-374
[8]  
BASS MB, 1984, J BIOL CHEM, V259, P2330
[9]   Xanthine Oxidoreductase in Drug Metabolism: Beyond a Role as a Detoxifying Enzyme [J].
Battelli, Maria Giulia ;
Polito, Letizia ;
Bortolotti, Massimo ;
Bolognesi, Andrea .
CURRENT MEDICINAL CHEMISTRY, 2016, 23 (35) :4027-4036
[10]   Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes [J].
Bhargava, Pavan ;
Fitzgerald, Kathryn C. ;
Venkata, Swarajya L. V. ;
Smith, Matthew D. ;
Kornberg, Michael D. ;
Mowry, Ellen M. ;
Haughey, Norman J. ;
Calabresi, Peter A. .
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (01) :33-45